ROC curve analysis confirmed that GDF15 represents an excellent marker for the discrimination of individuals with advanced hepatic fibrosis (NFS > 0.76; n = 14) and without hepatic fibrosis (NFS < −1.455; n = 64) at study base-line (AUC = 0.910) (Figure 3F). Here, GDF15 is linked to Hepatic fibrosis.